Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report. // AACE Endocrinology and Diabetes. – URL: https://www.sciencedirect.com/science/article/pii/S3050915725001973?dgcid=rss_sd_all
Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report. AACE Endocrinology and Diabetes. https://www.sciencedirect.com/science/article/pii/S3050915725001973?dgcid=rss_sd_all
“Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report.” AACE Endocrinology and Diabetes.
@article{article88182,
title = {Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report},
journal = {AACE Endocrinology and Diabetes},
url = {https://www.sciencedirect.com/science/article/pii/S3050915725001973?dgcid=rss_sd_all}
}